MedPath
HSA Approval

ARISTO-LATA Latanoprost Eye Drops 0.005% w/v

SIN17024P

ARISTO-LATA Latanoprost Eye Drops 0.005% w/v

ARISTO-LATA Latanoprost Eye Drops 0.005% w/v

June 11, 2024

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION

OPHTHALMIC

Medical Information

S01EE01

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

RAFARM S.A.

Active Ingredients

Latanoprost

0.005%w/v

Latanoprost

Documents

Package Inserts

Aristo-LATA PI June 2024.pdf

Approved: June 11, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ARISTO-LATA Latanoprost Eye Drops 0.005% w/v - HSA Approval | MedPath